Access Biotechnology
Finance · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Arch House 66 Seymour Marble St Fl 6, Lo...Phone Number
(212) 247-6400Website
www.accessbio-tech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Access Biotechnology
Access Industries Biotechnology invests in transformative therapies aimed at addressing conditions with high unmet medical needs, significantly impacting human health. The firm, led by former Pfizer executive Liam Ratcliffe, manages a diverse portfolio of private and public biopharma investments across all therapeutic areas and development stages. Emphasizing a long-term, collaborative approach, they focus on developing effective treatments through partnerships with innovative biotech companies. Their investment strategy prioritizes fundamental value creation over market momentum, thereby enhancing the potential for patient and societal benefits.Explore more
Popular SearchesAccess BiotechnologySIC Code 67,679NAICS Code 52,523Show moreAccess Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Access Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Access Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Access Biotechnology launches new products
Earning: See what the market has to say on Access Biotechnology recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Access Biotechnology
Funding: Get notified immidiatlly once Access Biotechnology has new funding data
Check if Access Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Check out if Access Biotechnology is spiking on competitors!
Click to see if Access Biotechnology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Access Biotechnology
Find more new buyers
Company Profile Activity
Activity Insights
Access Biotechnology is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Access Biotechnology is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Access Biotechnology.
Access Biotechnology Tech Stack
A closer look at the technologies used by Access Biotechnology
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Access Biotechnology News & Media
Areteia Therapeutics Raises Additional $75M in Series A Financing
Areteia Therapeutics, a Chapel Hill, NC-based clinical stage biotechnology company, raised additional $75M in Series A funding. The round, which brought the total amount to $425M, saw support from Viking Global Investors and Marshall Wace, who joined the original syndicate of investors led by Bain Capital Life Sciences with participation from Access Biotechnology, GV, ARCH […] The post Areteia Therapeutics Raises Additional $75M in Series A Financing appeared first on FinSMEs.Mariana Oncology Raises USD175M in Series B Funding
Mariana Oncology, a Watertown MA-based fully integrated, next-generation radiopharmaceuticals company, raised $175m in Series B financing. The round was co-led by Forbion (the first investment by its Forbion Ventures Fund VI,) and Deep Track Capital, with participation from founding investors Atlas Venture, Access Biotechnology and RA Capital Management, and new investors Nextech Invest, Surveyor Capital […] The post Mariana Oncology Raises USD175M in Series B Funding appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Access Biotechnology
Sign Up For FreeTo access detailed company insights
Access Industries Biotechnology invests in transformative therapies aimed at addressing conditions with high unmet medical needs, significantly impacting human health. The firm, led by former Pfizer executive Liam Ratcliffe, manages a diverse portfolio of private and public biopharma investments across all therapeutic areas and development stages.... Read More
